1. A nomogram to predict non–sentinel lymph node metastasis in patients with initial cN+ breast cancer that downstages to cN0 after neoadjuvant chemotherapy. Issue 3 (20th May 2020) Authors: Cheng, Minyi; Zhuang, Xiaosheng; Zhang, Liulu; Zhu, Teng; Lin, Yufeng; Yang, Mei; Ji, Fei; Yang, Ciqiu; Gao, Hongfei; Wang, Kun Journal: Journal of surgical oncology Issue: Volume 122:Issue 3(2020) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Novel Predictive Nomogram including Serum Lipoprotein a Level for Nonsentinel Lymph Node Metastases in Chinese Breast Cancer Patients with Positive Sentinel Lymph Node Metastases. (22nd November 2021) Authors: Fang, Zeng; Wang, Ruizhi; Yang, Ciqiu; Wang, Dong; Chen, Wanna; Lin, Bo; Gong, Dongsheng; Li, Songqi; Liang, Jiadong; Liang, Xiaoli; Zeng, Chunxian; Li, Jie; Wang, Kun; Lv, Weiming Other Names: Shao Yi Academic Editor. Journal: Disease markers Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ceramide kinase confers tamoxifen resistance in estrogen receptor-positive breast cancer by altering sphingolipid metabolism. (January 2023) Authors: Huang, Cheng; Su, Liangping; Chen, Yitian; Wu, Sangqing; Sun, Ruipu; Xu, Qiuping; Qiu, Xiaoyi; Yang, Ciqiu; Kong, Xiangzhan; Qin, Hongquan; Zhao, Xinbao; Jiang, Xue; Wang, Kun; Zhu, Yinghua; Wong, Ping-Pui Journal: Pharmacological research Issue: Volume 187(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low-dose apatinib combined with neoadjuvant chemotherapy in the treatment of early-stage triple-negative breast cancer (LANCET): a single-center, single-arm, phase II trial. (August 2022) Authors: Yang, Ciqiu; Zhang, Junsheng; Zhang, Yi; Ji, Fei; Chen, Yitian; Zhu, Teng; Zhang, Liulu; Gao, Hongfei; Yang, Mei; Li, Jieqing; Cheng, Minyi; Wang, Kun Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prevention of taxane-associated acute pain syndrome with etoricoxib for patients with breast cancer: A phase II randomised trial. (August 2022) Authors: Zhang, Junsheng; Gao, Hong-Fei; Yang, Ciqiu; Zhu, Teng; Ji, Fei; Yang, Mei; Zhang, Liulu; Li, Jieqing; Cheng, Minyi; Zhang, Tingfeng; Shen, Bo; Chen, Yuanqi; Wang, Kun Journal: European journal of cancer Issue: Volume 171(2022) Page Start: 150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Survival differences between HER2-0 and HER2-low-expressing breast cancer − A meta-analysis of early breast cancer patients. (May 2023) Authors: Yang, Ciqiu; Zhang, Xiaoqi; Chen, Yitian; Li, Peiyong; Zhang, Junsheng; Xu, Aiqi; Huang, Na; Liang, Minting; Chen, Yilin; Wang, Kun Journal: Critical reviews in oncology/hematology Issue: Volume 185(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage metaplastic breast cancer: a population-based study of 2412 patients. (August 2021) Authors: Zhang, Junsheng; Yang, Ciqiu; Lei, Chuqian; Zhang, Yi; Ji, Fei; Gao, Hongfei; Yang, Mei; Zhang, Liulu; Li, Jieqing; Zhu, Teng; Li, Weiping; Zhuang, Xiaosheng; Wang, Kun Journal: Breast Issue: Volume 58(2021) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗